These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11835791)

  • 21. Hookworm infestation as a risk factor for Mooren's ulcer in South India.
    Zelefsky JR; Srinivasan M; Kundu A; Lietman T; Whitcher JP; Wang K; Buyse M; Cunningham ET
    Ophthalmology; 2007 Mar; 114(3):450-3. PubMed ID: 17123614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Mooren's and Mooren's-like ulcer by lamellar keratectomy: report of six eyes and literature review.
    Martin NF; Stark WJ; Maumenee AE
    Ophthalmic Surg; 1987 Aug; 18(8):564-9. PubMed ID: 3309765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of in vivo confocal scanning laser microscopy in the diagnosis and evaluation of treatment responses in Mooren's ulcer.
    Hatou S; Dogru M; Ibrahim OM; Wakamatsu T; Sato EA; Shimmura S; Negishi K; Tsubota K
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6680-9. PubMed ID: 21666242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amniotic membrane transplantation ineffective as additional therapy in patients with aggressive Mooren's ulcer.
    Schallenberg M; Westekemper H; Steuhl KP; Meller D
    BMC Ophthalmol; 2013 Dec; 13():81. PubMed ID: 24345289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The therapy of Mooren's rodent ulcer (author's transl)].
    Pau H
    Klin Monbl Augenheilkd; 1978 Jul; 173(1):62-8. PubMed ID: 692039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral Boston keratoprosthesis type 1 in a case of severe Mooren's ulcer.
    Jerez-Peña M; Salvador-Culla B; de la Paz MF; Barraquer RI
    Eur J Ophthalmol; 2021 Mar; 31(2):NP33-NP38. PubMed ID: 32141311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of amniotic membrane and autologous serum eye drops in Mooren's ulcer.
    Lavaju P; Sharma M; Sharma A; Chettri S
    Nepal J Ophthalmol; 2013; 5(1):120-3. PubMed ID: 23584659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Mooren's ulceration.
    Watson PG
    Eye (Lond); 1997; 11 ( Pt 3)():349-56. PubMed ID: 9373475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of Mooren's ulcer in South India.
    Srinivasan M; Zegans ME; Zelefsky JR; Kundu A; Lietman T; Whitcher JP; Cunningham ET
    Br J Ophthalmol; 2007 May; 91(5):570-5. PubMed ID: 17035269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid deterioration of Mooren's ulcers after conjunctival flap: a review of 2 cases.
    Li S; Deng Y; Du C; Huang H; Zhong J; Chen L; Wang B; Yuan J
    BMC Ophthalmol; 2017 Jun; 17(1):93. PubMed ID: 28619029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapsing Mooren's ulcer after amniotic membrane transplantation combined with conjunctival autografting.
    Chen KH; Hsu WM; Liang CK
    Ophthalmology; 2004 Apr; 111(4):792-5. PubMed ID: 15051214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically.
    Zhao JC; Jin XY
    Cornea; 1993 Nov; 12(6):481-8. PubMed ID: 8261778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cataract surgery in patients with Mooren's ulcer.
    Sangwan VS; Surender P; Burman S
    J Cataract Refract Surg; 2005 Feb; 31(2):359-62. PubMed ID: 15767159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression for Mooren's ulcer: evaluation of the stepladder approach--topical, oral and intravenous immunosuppressive agents.
    Ashar JN; Mathur A; Sangwan VS
    Br J Ophthalmol; 2013 Nov; 97(11):1391-4. PubMed ID: 23536419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninfectious peripheral corneal ulceration: Mooren's ulcer or Terrien's marginal degeneration?
    Binder PS; Zavala EY; Stainer GA
    Ann Ophthalmol; 1982 May; 14(5):425-6, 428-9, 432-5. PubMed ID: 7051935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A histochemical and immunohistochemical study of cornea and adjacent bulbar conjunctiva in Mooren's ulcer].
    Xie H; Chen J; Zheng H; Li Y; Liu W
    Yan Ke Xue Bao; 2000 Jun; 16(2):139-42, 152. PubMed ID: 12579925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
    Meskin SW; Carlson EM
    Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer.
    Kayukawa K; Kitazawa K; Wakimasu K; Sotozono C; Kinoshita S
    Am J Ophthalmol Case Rep; 2023 Mar; 29():101796. PubMed ID: 36718435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.